Jeffrey Arvin Fink
CIK: 0001595930
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LPCN
Lipocine Inc.
Director
Discretionary Trading P&L
Holdings
About Fink Jeffrey Arvin
Fink Jeffrey Arvin (SEC CIK 0001595930) files insider reports with the SEC as Director of Lipocine Inc. (LPCN).
Signal8 holds 1 ownership filing by Fink Jeffrey Arvin, a Form 4, filed on Jun 5, 2025. Those filings report 1 transaction, the latest on Jun 4, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Fink Jeffrey Arvin's filings is in SALT LAKE CITY, UT.
Recent filings by Fink Jeffrey Arvin
- Jun 4, 2025: Grant or award of LPCN derivative securities (Form 4, code A).
Other insiders filing for Lipocine Inc. (LPCN)
- Higuchi John W., Director
- Grissinger Michael, Director
- Jene Jill M., Director
- Ono Richard Dana, Director
- Patel Mahesh V., Chief Executive Officer
- Fogarty Krista, Principal Accounting Officer